Skip to main content
. 2020 Aug 7;8(2):e001053. doi: 10.1136/jitc-2020-001053

Figure 1.

Figure 1

The TME of HPV16+ OPSCC tumors is highly infiltrated with CD14CD33CD163+ myeloid cells. Paraffin-embedded OPSCC tissue of 20 patients was analyzed by triple immunofluorescent confocal microscopy analysis with antibodies directed against CD14 (red), CD33 (blue) and CD163 (green). (A) The left panel depicts an example of an OPSCC sample with dense infiltration of the stromal compartment. the right panel depicts examples of (1) a CD14+CD33+CD163+ cell, (2) a CD14+CD33CD163+ cell, (3) a CD14CD33+CD163 cell and (4) a CD14CD33CD163+ cell. (B) Scatter plot depicting (from left to right) CD14+CD33CD163, CD14+CD33CD163+, CD14+CD33+CD163, CD14+CD33+CD163+, CD14CD33+CD163 and CD14CD33CD163+ cell infiltrates/mm2 for each patient in the epithelium (top) and stroma (bottom). Cells were manually counted and represented as the number of cells per mm2 for each slide (average of five images at 250× magnification). (C) Scatter plots and correlation analysis between the number of total CD14CD33CD163+ myeloid cells/mm2 (epithelium+stroma; Y-axis) and total CD8+, CD8+Foxp3Tbet+ and CD4Foxp3Tbet+ (CD4, from left to right; X-axis) cells/mm2. Pearson’s correlation with the coefficient of determination (r2) and p value is depicted for each correlation analysis. The dotted lines represent the 95% CI. Data for total CD8+, CD8+Foxp3Tbet+ and CD8Foxp3Tbet+ (CD4) have been described before.3 (D) Stacked bar graph depicting (from top to bottom) CD14+CD33CD163, CD14+CD33CD163+, CD14+CD33+CD163, CD14+CD33+CD163+, CD14CD33+CD163 and CD14CD33CD163+ cell infiltrates/mm2 in eight HPV16+ immune response-negative (HPV16+IR; left) and 12 HPV16+IR+ (right) patients with OPSCC. (E) Kaplan-Meier survival curve showing the survival of 19 patients with OPSCC. The patients were grouped into low (blue) or high (red) based on the median numbers of CD14CD33CD163+ cells/mm2 of the total group. statistical significance of the survival distribution was analyzed by log-rank testing and differences were considered significant when p<0.05. HPV, human papillomavirus; OPSCC, oropharyngeal squamous cell carcinoma; TME, tumor microenvironment.